Veeva Systems Weighted Average Exercise Price of Exercisable Options increased by 0.0% to $182.00 in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $177.29 to $182.00.
An increase may suggest higher historical grant prices, while a decrease relative to market price indicates higher potential dilution risk.
This metric represents the weighted average price at which holders of vested share-based payment options can purchase co...
Standard disclosure for large-cap industrial firms with significant equity compensation programs.
weighted_avg_exercise_price_exercisable| Q1 '21 | Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $74.41 | $75.20 | $75.71 | $105.40 | $106.28 | $107.17 | $155.80 | $156.71 | $157.07 | $165.33 | $177.48 | $177.29 | $182.36 | $181.98 | $182.00 |
| QoQ Change | — | +1.1% | +0.7% | +39.2% | +0.8% | +0.8% | +45.4% | +0.6% | +0.2% | +5.3% | +7.3% | -0.1% | +2.9% | -0.2% | +0.0% |
| YoY Change | — | — | — | +41.6% | +41.3% | +41.6% | +47.8% | +47.5% | +46.6% | +6.1% | +13.3% | +12.9% | +10.3% | +2.5% | +2.7% |